Literature DB >> 20223816

Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis.

Carmen Pérez-Bocanegra1, Roser Solans-Laqué, Carmen P Simeón-Aznar, Mercedes Campillo, Vicente Fonollosa-Pla, Miquel Vilardell-Tarrés.   

Abstract

OBJECTIVE: To analyse the differences in SSc clinical features and survival in patients aged > or = 65 years compared with young SSc patients.
METHODS: Of a total of 319 SSc patients, we identified 67 (21%) patients aged >65 years. Demographical data such as SSc subsets, the cutaneous complaint, internal organ involvement and the causes of morbidity and mortality were collected. Results of the elderly and young patients were compared.
RESULTS: There were 61 (91%) women and 6 (9%) men aged > or = 65 years. The limited SSc (lSSc) subset was more prevalent in elderly than in young patients (74.6 vs 54%, P = 0.002). Pulmonary disease (86.6% in elderly vs 73.8% in young patients, P = 0.034) and cardiac involvement (70.1% in elderly vs 49.6% in young patients, P = 0.004) were significantly more prevalent in elderly patients. In contrast, signs of oesophageal involvement (43.3% in elderly vs 57.5% in young patients, P = 0.040) were less frequent in aged patients. In addition, pulmonary and heart disease appeared significantly earlier after the diagnosis in patients aged > or = 65 years. Mortality was significantly higher in elderly than in young patients (35.8 vs 19%, P = 0.005), but when standardized mortality ratios (SMRs) were analysed, there was no significant mortality increase in the elderly.
CONCLUSION: In elderly patients, the lSSc subset is more prevalent than the diffuse. Pulmonary and cardiac involvement are more prevalent in aged patients and appears sooner after the disease diagnosis. SSc is clearly related to increased mortality, although it is not significant in the elderly group.

Entities:  

Mesh:

Year:  2010        PMID: 20223816     DOI: 10.1093/rheumatology/keq046

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

Review 1.  Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?

Authors:  Tracy R Luckhardt; Victor J Thannickal
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

2.  Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.

Authors:  Anne E Wyman; Zahid Noor; Rita Fishelevich; Virginia Lockatell; Nirav G Shah; Nevins W Todd; Sergei P Atamas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-06       Impact factor: 5.464

Review 3.  Sirtuins and Accelerated Aging in Scleroderma.

Authors:  Anne E Wyman; Sergei P Atamas
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

4.  Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.

Authors:  Hadi Poormoghim; Elham Andalib; Arash Jalali; Afshin Ghaderi; Ali Ghorbannia; Nazanin Mojtabavi
Journal:  Rheumatol Int       Date:  2016-04-09       Impact factor: 2.631

5.  Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis : An updated meta-analysis.

Authors:  Y H Lee
Journal:  Z Rheumatol       Date:  2019-03       Impact factor: 1.372

6.  Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.

Authors:  Xue Li; Yu-Quan Qian; Na Liu; Rong Mu; Yu Zuo; Guo-Chun Wang; Yuan Jia; Zhan-Guo Li
Journal:  Clin Rheumatol       Date:  2018-09-18       Impact factor: 2.980

7.  Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.

Authors:  Devi Kundu; David Abraham; Carol M Black; Christopher P Denton; K Richard Bruckdorfer
Journal:  Vascul Pharmacol       Date:  2014-10-15       Impact factor: 5.773

Review 8.  The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy.

Authors:  Amaal E Abdulle; Gilles F H Diercks; Martin Feelisch; Douwe J Mulder; Harry van Goor
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

9.  Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.

Authors:  C P Simeón-Aznar; V Fonollosa-Plá; Carles Tolosa-Vilella; G Espinosa-Garriga; M Campillo-Grau; M Ramos-Casals; F J García-Hernández; M J Castillo-Palma; J Sánchez-Román; J L Callejas-Rubio; N Ortego-Centeno; M V Egurbide-Arberas; L Trapiellla-Martínez; L Caminal-Montero; L Sáez-Comet; J Velilla-Marco; M T Camps-García; E de Ramón-Garrido; E M Esteban-Marcos; L Pallarés-Ferreres; N Navarrete-Navarrete; J A Vargas-Hitos; R Gómez de la Torre; G Salvador-Cervello; J J Rios-Blanco; M Vilardell-Tarrés
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.

Authors:  Marco A Alba; César Velasco; Carmen Pilar Simeón; Vicent Fonollosa; Luis Trapiella; María Victoria Egurbide; Luis Sáez; María Jesús Castillo; José Luis Callejas; María Teresa Camps; Carles Tolosa; Juan José Ríos; Mayka Freire; José Antonio Vargas; Gerard Espinosa
Journal:  Medicine (Baltimore)       Date:  2014-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.